USPTO trademark

RIZVIIMI

RegisteredUSPTOWord markClass 5

"RIZVIIMI" is a word mark owned by Glaxo Group Limited, filed at the USPTO on March 27, 2025. It is registered and covers class 5 (Pharmaceuticals).

View Glaxo Group Limited portfolioGet this data via the API
Official USPTO record
RIZVIIMI trademark as filed
As filed with the USPTO
Status
Registered
Since December 23, 2025
Filed
March 27, 2025
Registered
December 23, 2025
Priority date
February 7, 2025
Claimed from United Kingdom
Application no.
99107336
Registration no.
8075634
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
1 class
Ownership

Who owns RIZVIIMI

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Glaxo Group Limited

Stevenage, United Kingdom

19,383 trademarks in the portfolioView company

Representative

Christopher M. Hanes

GSK

Goods and services

What the mark covers

The products and services RIZVIIMI is filed for, grouped by Nice class.

  • Vaccines; Anti-infectives; Pharmaceutical preparations for the treatment of damaged skin and tissue, pain, inflammation, obesity, and infectious diseases; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, bacterial, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders; Pharmaceutical preparations for the prevention of infectious diseases

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Notice of registration confirmation emailed
  2. Registered-principal register
  3. Official gazette publication confirmation e-mailed
  4. Published for opposition
  5. Notification of notice of publication e-mailed
  6. Approved for pub - principal register
  7. Teas/email correspondence entered
  8. Correspondence received in law office
  9. Teas response to suspension inquiry received
  10. Notification of letter of suspension e-mailed

6 earlier steps on the official record.

FAQ

About RIZVIIMI

Who owns the trademark "RIZVIIMI"?

The USPTO trademark "RIZVIIMI" (application 99107336) is owned by Glaxo Group Limited.

What is the status of "RIZVIIMI"?

Its status at the USPTO is: registered.

When was "RIZVIIMI" registered?

It was registered on December 23, 2025.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull RIZVIIMI and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019d2a9b-4e24-7235-8b09-2e797809cf27
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d2a9b-4e24-7235-8b09-2e797809cf27",
  "object": "trademark",
  "mark_text": "RIZVIIMI",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "US",
  "application_number": "99107336",
  "filing_date": "2025-03-27",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "Glaxo Group Limited",
      "entity_id": "ent_019eb6f6-4cb9-77ae-916f-63b3231a6d3d"
    }
  ]
}